Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Low dose aspirin and cognitive function in the women's health study cognitive cohort.

Kang JH, Cook N, Manson J, Buring JE, Grodstein F.

BMJ. 2007 May 12;334(7601):987. Epub 2007 Apr 27.

2.

A randomized trial of vitamin E supplementation and cognitive function in women.

Kang JH, Cook N, Manson J, Buring JE, Grodstein F.

Arch Intern Med. 2006 Dec 11-25;166(22):2462-8.

PMID:
17159011
3.

Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study.

Kang JH, Cook NR, Manson JE, Buring JE, Albert CM, Grodstein F.

Circulation. 2009 Jun 2;119(21):2772-80. doi: 10.1161/CIRCULATIONAHA.108.816900. Epub 2009 May 18.

4.

Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial.

Price JF, Stewart MC, Deary IJ, Murray GD, Sandercock P, Butcher I, Fowkes FG; AAA Trialists.

BMJ. 2008 Sep 1;337:a1198. doi: 10.1136/bmj.a1198.

5.

Mediterranean diet and cognitive decline in women with cardiovascular disease or risk factors.

Vercambre MN, Grodstein F, Berr C, Kang JH.

J Acad Nutr Diet. 2012 Jun;112(6):816-23. doi: 10.1016/j.jand.2012.02.023.

6.

A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II.

Grodstein F, Kang JH, Glynn RJ, Cook NR, Gaziano JM.

Arch Intern Med. 2007 Nov 12;167(20):2184-90.

PMID:
17998490
7.

Migraine and cognitive decline among women: prospective cohort study.

Rist PM, Kang JH, Buring JE, Glymour MM, Grodstein F, Kurth T.

BMJ. 2012 Aug 8;345:e5027. doi: 10.1136/bmj.e5027.

8.

Seafood types and age-related cognitive decline in the Women's Health Study.

Kim DH, Grodstein F, Rosner B, Kang JH, Cook NR, Manson JE, Buring JE, Willett WC, Okereke OI.

J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1255-62. doi: 10.1093/gerona/glt037. Epub 2013 Apr 3.

9.

Long-term multivitamin supplementation and cognitive function in men: a randomized trial.

Grodstein F, O'Brien J, Kang JH, Dushkes R, Cook NR, Okereke O, Manson JE, Glynn RJ, Buring JE, Gaziano M, Sesso HD.

Ann Intern Med. 2013 Dec 17;159(12):806-14.

10.

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2663-72.

PMID:
12771113
11.

Caffeine and cognitive decline in elderly women at high vascular risk.

Vercambre MN, Berr C, Ritchie K, Kang JH.

J Alzheimers Dis. 2013;35(2):413-21. doi: 10.3233/JAD-122371.

12.
13.

Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline.

Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M; MIDAS Investigators.

Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013.

14.

Dietary fat intake in relation to cognitive change in high-risk women with cardiovascular disease or vascular factors.

Vercambre MN, Grodstein F, Kang JH.

Eur J Clin Nutr. 2010 Oct;64(10):1134-40. doi: 10.1038/ejcn.2010.113. Epub 2010 Jul 21.

15.

Physical activity and cognition in women with vascular conditions.

Vercambre MN, Grodstein F, Manson JE, Stampfer MJ, Kang JH.

Arch Intern Med. 2011 Jul 25;171(14):1244-50. doi: 10.1001/archinternmed.2011.282. Epub 2011 Jul 19.

16.

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A; SCOPE Study Group.

J Hypertens. 2003 May;21(5):875-86.

PMID:
12714861
17.

A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease.

Freiheit EA, Hogan DB, Eliasziw M, Patten SB, Demchuk AM, Faris P, Anderson T, Galbraith D, Parboosingh JS, Ghali WA, Knudtson M, Maxwell CJ.

Arch Gen Psychiatry. 2012 Mar;69(3):244-55. doi: 10.1001/archgenpsychiatry.2011.1361.

PMID:
22393217
18.

A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.

Almeida OP, Lautenschlager NT, Vasikaran S, Leedman P, Gelavis A, Flicker L.

Neurobiol Aging. 2006 Jan;27(1):141-9. Epub 2005 Mar 16.

PMID:
16298249
19.

Plasma C peptide level and cognitive function among older women without diabetes mellitus.

Okereke O, Hankinson SE, Hu FB, Grodstein F.

Arch Intern Med. 2005 Jul 25;165(14):1651-6.

PMID:
16043685
20.

Cognitive function in postmenopausal women treated with raloxifene.

Yaffe K, Krueger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA, Nickelsen T; Multiple Outcomes of Raloxifene Evaluation Investigators.

N Engl J Med. 2001 Apr 19;344(16):1207-13.

Supplemental Content

Support Center